Health Trials

Clinical trials

2

Search and review clinical trials. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

KYSA-6: A Study of Anti-CD19 Chimeric Antigen Receptor T-Cell Therapy, in Patients With Generalized Myasthenia Gravis

A Study of the Anti-CD 19 Chimeric Antigen Receptor T Cell Therapy for Patients with Myasthenia Gravis

Participants needed: 66
Trial details
Phase: Phase 2, Phase 3Age: 18-75Biological sex: AllType: InterventionalSponsor: Kyverna TherapeuticsUpdated: May 15, 2026Locations: 17
Eligibility criteria

Presence of autoantibodies to AChR or MuSK [+9]

Unable to washout or interrupt autoimmune disease therapy prior to apheresis and... [+8]

Read more
Status: Recruiting

A Long-Term Follow-Up Study for Participants Previously Treated With KYV-101

The purpose of this long-term follow-up (LTFU) study is to collect delayed adverse events (AEs) and understand the persistence of KYV-101 (autologous CAR T cell product; gene-modified product), in participants who have been administered KYV-101 (gene-modified product; autologous CAR T cell product). This LTFU protocol will be open to any participant who received at least one infusion of KYV-101 in a previous Kyverna sponsored clinical trial or Investigator Initiated Trial (IIT).

Participants needed: 70
Trial details
Age: 18+Biological sex: AllType: ObservationalSponsor: Kyverna TherapeuticsUpdated: Feb 11, 2026Locations: 1
Eligibility criteria

Provided informed consent for the LTFU study [+1]

Not applicable

Read more